PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
47.85%
Positive revenue growth while MAXN is negative. John Neff might see a notable competitive edge here.
40.78%
Gross profit growth at 50-75% of MAXN's 73.39%. Martin Whitman would question if cost structure or brand is lagging.
13.17%
EBIT growth below 50% of MAXN's 71.83%. Michael Burry would suspect deeper competitive or cost structure issues.
13.17%
Operating income growth under 50% of MAXN's 66.50%. Michael Burry would be concerned about deeper cost or sales issues.
12.45%
Net income growth under 50% of MAXN's 73.10%. Michael Burry would suspect the firm is falling well behind a key competitor.
82.61%
EPS growth of 82.61% while MAXN is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
82.61%
Diluted EPS growth 1.25-1.5x MAXN's 73.09%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
403.26%
Share change of 403.26% while MAXN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
403.26%
Diluted share change of 403.26% while MAXN is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
206.87%
OCF growth above 1.5x MAXN's 93.92%. David Dodd would confirm a clear edge in underlying cash generation.
94.69%
FCF growth similar to MAXN's 91.23%. Walter Schloss would attribute it to parallel capital spending and operational models.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-18.42%
Our R&D shrinks while MAXN invests at 3.39%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
22.39%
We expand SG&A while MAXN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.